Color Health is a US healthcare company that operates a virtual cancer clinic and precision medicine platform serving employers, health plans, unions, and public health organizations. Founded in 2015 in Burlingame, California by Elad Gil, Othman Laraki, Nish Bhat, and Taylor Sittler, the company began as Color Genomics focused on hereditary cancer testing and evolved into a full-stack oncology care delivery platform. Othman Laraki serves as CEO.
The company's flagship offering combines genetic risk assessment, screening logistics, oncologist-led virtual care, treatment planning support, and survivorship navigation into one program. Color works with local providers to ensure that members receive coordinated care from screening through diagnosis, active treatment, and return to work. The platform places heavy emphasis on early detection, equitable access, and cost containment for self-insured employers and large public health programs.
Color has raised approximately $491 million across multiple rounds from General Catalyst, T. Rowe Price, Khosla Ventures, and others. Its most recent disclosed round was a $100 million Series E in November 2021 that valued the company at $4.6 billion. The company previously played a major role in scaling US COVID-19 testing infrastructure during the pandemic, work that informed its current population-scale care delivery model.
Color now operates one of the larger virtual oncology programs in the country, with partnerships covering Fortune 500 employers and national public health initiatives. Its differentiation rests on combining genomics, clinical care delivery, and software infrastructure under a single roof, with a focus on cancer outcomes at population scale.